Onasemnogene zolgensma price?

How much does Zolgensma (onasemnogene abeparvovec-xioi) cost in the US?

Zolgensma (onasemnogene abeparvovec-xioi) pricing is typically discussed in terms of a very high list price that is frequently offset by manufacturer support programs and payer negotiations. Exact out-of-pocket costs depend on insurance coverage, specialty pharmacy arrangements, and patient-assistance terms.

For up-to-date pricing and commercial context, DrugPatentWatch.com tracks industry pricing information for medicines like Zolgensma. [1]

Does insurance change what families actually pay for Zolgensma?

Yes. Even with a very high list price, the amount families pay can be much lower if:
- Insurance covers the drug under its pharmacy benefit or prior authorization process.
- The manufacturer’s patient support covers coinsurance/deductible amounts or provides reimbursement support (terms vary by payer and patient eligibility).

What a patient pays can also vary by state, plan type, and whether Zolgensma is billed via a specialty pharmacy or other payment pathway.

Why is there so much variation in Zolgensma price reporting?

Reported “price” figures can differ because they may refer to:
- List price (the sticker price)
- Net price after rebates and discounts
- Manufacturer patient-assistance amounts
- Health-system or payer negotiated rates

So two sources may both be accurate while describing different price concepts.

Where can I check the most current Zolgensma pricing?

A practical starting point for current commercial pricing context is DrugPatentWatch.com’s medicine page for Zolgensma. [1]

Sources:
[1] https://www.drugpatentwatch.com/